Table of Contents

June 1, 2020; Volume 61,Issue 6

  1. Ranganathan, David

    1. 64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor–Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial
      Ebrahim S. Delpassand, David Ranganathan, Nilesh Wagh, Afshin Shafie, Ayman Gaber, Ali Abbasi, Andreas Kjaer, Izabela Tworowska and Rodolfo Núñez
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.119.236091

  2. Reynolds, Michael R.

    1. Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors
      Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong and Lisa A. Porter
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 904-910; DOI: https://doi.org/10.2967/jnumed.119.231068

  3. Riad, Aladdin

    1. PARP-1–Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
      Hwan Lee, Aladdin Riad, Paul Martorano, Adam Mansfield, Minu Samanta, Vandana Batra, Robert H. Mach, John M. Maris, Daniel A. Pryma and Mehran Makvandi
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 850-856; DOI: https://doi.org/10.2967/jnumed.119.233965

  4. Roach, Paul

    1. 3-Year Freedom from Progression After 68Ga-PSMA PET/CT–Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial
      Louise Emmett, Reuben Tang, Rohan Nandurkar, George Hruby, Paul Roach, Jo Anne Watts, Thomas Cusick, Andrew Kneebone, Bao Ho, Lyn Chan, Pim J. van Leeuwen, Matthijs J. Scheltema, Andrew Nguyen, Charlotte Yin, Andrew Scott, Colin Tang, Michael McCarthy, Karen Fullard, Matthew Roberts, Roslyn Francis and Phillip Stricker
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 866-872; DOI: https://doi.org/10.2967/jnumed.119.235028

  5. Roberts, Matthew

    1. 3-Year Freedom from Progression After 68Ga-PSMA PET/CT–Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial
      Louise Emmett, Reuben Tang, Rohan Nandurkar, George Hruby, Paul Roach, Jo Anne Watts, Thomas Cusick, Andrew Kneebone, Bao Ho, Lyn Chan, Pim J. van Leeuwen, Matthijs J. Scheltema, Andrew Nguyen, Charlotte Yin, Andrew Scott, Colin Tang, Michael McCarthy, Karen Fullard, Matthew Roberts, Roslyn Francis and Phillip Stricker
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 866-872; DOI: https://doi.org/10.2967/jnumed.119.235028

  6. Rose, Jed E.

    1. Rapid Brain Nicotine Uptake from Electronic Cigarettes
      Kiran Kumar Solingapuram Sai, Yantao Zuo, Jed E. Rose, Pradeep K. Garg, Sudha Garg, Rachid Nazih, Akiva Mintz and Alexey G. Mukhin
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 928-930; DOI: https://doi.org/10.2967/jnumed.119.230748

  7. Rossi, Sabrina

    1. Hyperprogressive Disease in Patients with Non–Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of 18F-FDG PET/CT
      Angelo Castello, Sabrina Rossi, Emanuela Mazziotti, Luca Toschi and Egesta Lopci
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 821-826; DOI: https://doi.org/10.2967/jnumed.119.237768

  8. Roy, Sudipta

    1. Preclinical PERCIST and 25% of SUVmax Threshold: Precision Imaging of Response to Therapy in Co-clinical 18F-FDG PET Imaging of Triple-Negative Breast Cancer Patient–Derived Tumor Xenografts
      Madhusudan A. Savaikar, Timothy Whitehead, Sudipta Roy, Lori Strong, Nicole Fettig, Tina Prmeau, Jingqin Luo, Shunqiang Li, Richard L. Wahl and Kooresh I. Shoghi
      Journal of Nuclear Medicine June 1, 2020, 61 (6) 842-849; DOI: https://doi.org/10.2967/jnumed.119.234286
Back to top

In this issue